NCT01329419 - HEPSERA Post Marketing Surveillance | Biotech Hunter

Enrollment

4,393

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Hepatitis B

Interventions

DRUG

adefovir dipivoxil

Basically there is no treatment allocation. Subjects who would be administered of adefovir at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.